General information

Announcements(0)

Program

Sessions

Search presentations

Download PDF for print

en.png

icon_20251202230259873.png

Change account information such as the email address and password on the account setting screen common to Confit.

Login required to view

Password required to view

Presentation Information

Session Details

Abstract password authentication. A password is required to view the full text of the abstract. Please refer to the member site for the password. https://membership.jnss.org/C00/login

To browse or post comments, you must log in.

You cannot post comments as it is outside the comment posting period.

This comment has been deleted. You cannot reply to this comment.

Program Type

Announcements

Profile management

Bookmark

Timetable

iPSC-derived neurons produced by Quick-TissueTM Technology: innovative materials for neurological disease research and drug discovery

The creation of human iPS cells is expected to realize previously difficult drug discovery technologies and pathological analysis. In this seminar, two speakers will talk about recent topics on iPS cell-derived neurons under the title of "Challenges in Drug Discovery Research Using High-Speed iPS Induced Differentiation Technology (Quick-Tissue™ Technology)". The first speaker is Dr. Sekino. The numerous spine structures on the dendrites of pyramidal neurons in the mature brain are microstructures discovered by Ramon y Cajal. Their shape is known to vary depending on the state of the internal actin cytoskeleton. Drebrin, a protein whose expression changes with brain development, is an actin-binding protein that localizes to dendritic spines. We will discuss the memory mechanism from the viewpoint of the dynamic regulation of the actin cytoskeleton by drebrin. The next lecture will be given by Dr. Aiba. Disease-specific iPSC lines are expected to overcome the difficulty of obtaining conventional patient-derived materials and contribute to the advancement of neurological disease and drug discovery research. However, there are challenges in the current situation where many researchers are not fully benefiting from these advantages. The main reasons for this include the immaturity of neurons derived from iPSCs and the difficulty in readily utilizing multiple patient-derived iPSC lines. Our Quick tissue™ technology can solve these problems. In this luncheon seminar, I will provide an overview of the Quick tissue™ technology and the characteristics of the neurons generated by this technique.

The 46th Annual Meeting of the Japan Neuroscience Society

Presentation Information

[1LS02-02]iPSC-derived neurons produced by Quick-Tissue^TM Technology: innovative materials for neurological disease research and drug discovery

Presentation Information

[1LS02-02]iPSC-derived neurons produced by Quick-TissueTM Technology: innovative materials for neurological disease research and drug discovery

[1LS02-02]iPSC-derived neurons produced by Quick-Tissue^TM Technology: innovative materials for neurological disease research and drug discovery